Revenue Decline – Talk Bio

Puma Biotechnology Reports Third Quarter 2025 Financial Results

1 month ago talkbio0Tagged beat, Clinical Trials, EPS, exophthalmos producing substance, financial results, Neoplasms, Nerlynx sales, net income, Puma Biotechnology, Q3, Revenue Decline, revenue guidance

Puma Biotechnology; Q3 2025; financial results; EPS beat; revenue decline; Nerlynx sales; net income; oncology; clinical trials; revenue guidance

Pfizer Cuts 11 R&D Programs amid Ongoing Revenue Declines and Cost Realignment Efforts

1 month ago talkbio0Tagged Cost Savings, COVID19 (disease), digital enablement, earnings, Pfizer, Q3, R&D, Revenue Decline, Seagen acquisition

Pfizer; R&D cuts; revenue decline; cost savings; Q3 2025 earnings; COVID-19 product sales; digital enablement; AI in R&D; Seagen acquisition

J&J’s Stelara Revenue Plummets as Biosimilar Competition Intensifies in 2025

5 months ago talkbio0Tagged Autoimmune Diseases, Benefit, Biosimilars, drug price, formulary exclusion, Johnson & Johnson, manager, Pharmaceutical Services, Revenue Decline, Stelara, ustekinumab

Stelara; Johnson & Johnson; ustekinumab; biosimilars; revenue decline; Q2 2025; pharmacy benefit managers; formulary exclusion; drug pricing; autoimmune disease

WuXi AppTec Faces Revenue Decline Amid Looming BIOSECURE Act Threat

1 year ago talkbio0Tagged AppTec, BIOSECURE, Biotechnology, Relations, Revenue Decline, WuXi

WuXi AppTec, BIOSECURE Act, Revenue Decline, Biotechnology, US-China Relations